CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 2.55K shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 9.70K shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 56.39K shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 11.65K shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 86.64K shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 171.41K shares, a 53.80% decline from fiscal 2020.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 371.01K shares, a 58.83% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 11.65K shares 10-K · filed 2026-03-30 |
| 2023-12-31 | 2.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 86.64K shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 9.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2023-06-30 | 56.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | |
| 2023-03-31 | 18.00K shares 10-Q · filed 2023-05-02 | |
| 2021-12-31 | 6.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 171.41K shares 10-K · filed 2024-03-15 |
| 2021-09-30 | 113.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 215.04K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | 34.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 136.99K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | 17.03K shares 10-Q · filed 2021-05-04 | 349.76K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | 49.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 371.01K shares 10-K · filed 2023-03-09 |
| 2020-09-30 | 35.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 322.48K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | 247.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 373.25K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | 38.28K shares 10-Q · filed 2020-05-05 | 216.22K shares derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | 1.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 233.58K shares 10-K · filed 2022-03-10 |
| 2019-09-30 | 86.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 369.15K shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-06-30 | 90.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 421.02K shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2019-03-31 | 55.64K shares 10-Q · filed 2019-05-07 | 682.43K shares derived: sum of 4 quarters · filed 2021-03-09 |
| 2018-12-31 | 136.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 856.28K shares 10-K · filed 2021-03-09 |
| 2018-09-30 | 138.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 834.28K shares derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | 351.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 746.03K shares derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | 229.50K shares 10-Q · filed 2018-05-08 | 404.38K shares derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | 114.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | 188.85K shares 10-K · filed 2020-03-05 |
| 2017-09-30 | 50.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 85.18K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | 10.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 58.16K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | 13.96K shares 10-Q · filed 2017-05-08 | 49.16K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | 11.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 36.20K shares 10-K · filed 2019-03-07 |
| 2016-09-30 | 23.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 89.71K shares derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 203.59K shares derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | 1.00K shares 10-Q · filed 2016-05-09 | 329.23K shares derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | 64.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 339.62K shares 10-K · filed 2018-03-08 |
| 2015-09-30 | 137.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -2.07M shares derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | 126.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -1.36M shares derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | 11.40K shares 10-Q · filed 2015-05-11 | -1.31M shares derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | -2.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | 117.25K shares 10-K · filed 2017-03-03 |
| 2014-09-30 | 850.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 1.93M shares derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-06-30 | 175.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 1.14M shares derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-03-31 | 1.44M shares 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -534.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | 22.27K shares 10-K · filed 2015-03-31 |
| 2013-09-30 | 60.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | |
| 2012-12-31 | 303.04K shares 10-K · filed 2014-03-31 | |
| 2011-12-31 | 146.88K shares 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |